The upregulation of linc00641 suppressed the proliferation, migration and invasion of bladder cancer cells and blocked tumor growth in vivo by interacting with miR-197-3p and targeting KLF10, leading to the inactivation of the PTEN/PI3K/Akt pathway [11]. The gene discussed is AKT1; the disease is urinary bladder cancer.